Welcome to LookChem.com Sign In|Join Free
  • or
octadecyl (R)-12-hydroxyoleate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

93980-70-2

Post Buying Request

93980-70-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

93980-70-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 93980-70-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,9,8 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 93980-70:
(7*9)+(6*3)+(5*9)+(4*8)+(3*0)+(2*7)+(1*0)=172
172 % 10 = 2
So 93980-70-2 is a valid CAS Registry Number.

93980-70-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name octadecyl (Z)-12-hydroxyoctadec-9-enoate

1.2 Other means of identification

Product number -
Other names Ricinoleic Acid stearyl Ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:93980-70-2 SDS

93980-70-2Upstream product

93980-70-2Downstream Products

93980-70-2Relevant academic research and scientific papers

Polyanhydrides

-

, (2008/06/13)

The invention provides polyanhydrides with aliphatic hydrocarbon terminals having ester or amide bonds.

Polymeric formulations for drug delivery

-

, (2008/06/13)

Poly(ester-anhydrides) or polyesters formed from ricinoleic acid and natural fatty diacids and their method of preparation and its use for delivering bioactive agents including small drug molecules, peptides and proteins, DNA and DNA complexes with cationic lipids or polymers or nano and microparticles loaded with bioactive agents are disclosed herein. The drug delivery compositions are administered to a patient in a liquid form, increase in viscosity in vivo to form a drug depot or implant, and are able to release the incorporated bioactive agent for weeks. In the preferred embodiment, the drug delivery formulations are administered by injection. In one embodiment, the compositions are suitable for local or regional delivery of drugs to diseased sites, such as treating solid tumors and bone infections. In a preferred embodiment, the drug delivery compositions are suitable for site-specific chemotherapy for the treatment of solid tumors including: squamous cell carcinoma (SCC) of the head and neck, prostate cancer, and sarcomas for intratumoral injection or insertion.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 93980-70-2